UBS’s VIROPHARMA INC VPHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-20,136
Closed -$1M 11416
2013
Q4
$1M Buy
20,136
+15,446
+329% +$691K ﹤0.01% 3541
2013
Q3
$184K Buy
4,690
+2,855
+156% +$93.3K ﹤0.01% 5286
2013
Q2
$53K Buy
+1,835
New +$48.4K ﹤0.01% 6666

UBS's VPHM Position: Q1 2014 in Review

UBS sold out of VIROPHARMA INC (VPHM) in Q1 2014, closing a stake of 20,136 shares — an estimated $1M sold.

UBS first reported a position in VPHM in Q2 2013 and held it in 3 quarters. The position peaked at $1M in Q4 2013. 0 funds tracked by Wall St. Rank hold VPHM as of Q1 2014.

  • UBS reported no remaining VIROPHARMA INC position as of Q1 2014 after selling out during the quarter.
  • UBS sold 20,136 VIROPHARMA INC shares in Q1 2014, an estimated $1M.
  • UBS first reported a position in VIROPHARMA INC in Q2 2013 and held it in 3 quarters.
  • UBS's VIROPHARMA INC position peaked at $1M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q1 2014.

Based on UBS's 13F filing for Q1 2014, filed 15 May 2014.